Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients

Introduction: High-risk patients with grade 3 endometrioid endometrial carcinoma (G3EEC) who require adjuvant therapy have not been clearly identified. Therefore, the current study aimed to investigate the prognostic impact of ARID1A, p53, and mismatch repair (MMR) protein expressions, previously re...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pathol Oncol Res
Huvudupphovsmän: Kato, Mayumi Kobayashi, Yoshida, Hiroshi, Tanase, Yasuhito, Uno, Masaya, Ishikawa, Mitsuya, Kato, Tomoyasu
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2021
Ämnen:
Society Journal Archive
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262237/
https://ncbi.nlm.nih.gov/pubmed/34257552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.598550
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk